Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sikarin PCLBKK:SKR -0.62%91 Market Cap is ฿16,193 Mil as of Jul. 19, 2026. GuruFocus rates BKK:SKR with a GF Score™ of 91/100 and a GF Value™ of ฿9.12 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Sikarin PCL ranks better than 71.37% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sikarin PCL's share price for the quarter that ended in Mar. 2026 was ฿7. Sikarin PCL's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 2,033 Mil. Therefore, Sikarin PCL's market cap for the quarter that ended in Mar. 2026 was ฿14,234 Mil.
Sikarin PCL's quarterly market cap
declined
from Sep. 2025 (฿16,177 Mil) to Dec. 2025 (฿14,346 Mil) and
declined
from Dec. 2025 (฿14,346 Mil) to Mar. 2026 (฿14,234 Mil).
Sikarin PCL's annual market cap
declined
from Dec. 2023 (฿20,990 Mil) to Dec. 2024 (฿19,858 Mil) and
declined
from Dec. 2024 (฿19,858 Mil) to Dec. 2025 (฿14,346 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sikarin PCL's Enterprise Value for Today is ฿15,235 Mil.
Sikarin PCL (BKK:SKR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sikarin PCL Market Cap Related Terms
Sikarin PCL Market Cap Historical Data
* Premium members only.
The historical data trend for Sikarin PCL's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Sikarin PCL's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sikarin PCL Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sikarin PCL's Market Cap distribution charts can be found below:
* The bar in red indicates where Sikarin PCL's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sikarin PCL's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sikarin PCL (BKK:SKR) has a Market Cap of ฿16,193 Mil as of Jul. 19, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sikarin PCL and its competitors. According to the industry distribution chart, Sikarin PCL ranks #199 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 28.6%.
Is Sikarin PCL's Market Cap too high?
Sikarin PCL's current Market Cap is ฿16,193 Mil. Based on the distribution chart, Sikarin PCL ranks #199 out of 695 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sikarin PCL has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sikarin PCL's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sikarin PCL ranks #199 out of 695 companies for Market Cap. This puts Sikarin PCL in the upper half of its industry. The industry median Market Cap is 103.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 103.20, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sikarin PCL and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 103.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sikarin PCL's current Market Cap is ฿16,193 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sikarin PCL stock overvalued right now?
Based on GuruFocus' analysis, Sikarin PCL (BKK:SKR) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿9.12, compared to a current price of ฿8.00 — trading 12.3% below its estimated fair value. The current Market Cap is ฿16,193 Mil. Sikarin PCL's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sikarin PCL (BKK:SKR), the current Market Cap is ฿16,193 Mil as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sikarin PCL (BKK:SKR) Overvalued in 2026?
Based on GuruFocus' analysis, Sikarin PCL stock appears to be undervalued.
The current stock price of ฿8.00 is trading 12.3% below its estimated GF Value™ of ฿9.12.
GuruFocus considers Sikarin PCL to be Modestly Undervalued.
Key valuation signals for BKK:SKR:
Market Cap: ฿16,193 Mil
GF Value™: ฿9.12 vs. price of ฿8.00 (12.3% below fair value)
No single metric tells the full story. See the BKK:SKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSikarin PCL provides general healthcare services and operates under the social security system. The Group has one main operating segment, which is providing healthcare services through private hospitals and hospitals affiliated with the social security system. The Group operates in a single geographical area, which is Thailand. Its services include medical centers, a pediatric center, a women's institute, a radiology center, a neurology center, a rehabilitation center, and an orthopedic center.
91GF Score
Get the complete analysis for BKK:SKR
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKR has been successfully added to your 
